FDA Inspection 1209601 — Janssen Research and Development, LLC
The FDA completed an inspection of Janssen Research and Development, LLC on June 16, 2023 in Somerville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerville, NJ (United States)
Additional Details
Sponsor, Contract Research Organization